1. UMR U1236, INSERM, Université Rennes 1, Etablissement Français du Sang Bretagne, Equipe Labellisée Ligue Contre le Cancer, Rennes, France;
2. Centre Hospitalier Universitaire (CHU) de Rennes, Service d’Hématologie Clinique, Rennes, France;
3. Centre for Translational Inflammation Research, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham Research Laboratories, Queen Elizabeth Hospital, Birmingham, United Kingdom;
4. CHU de Rennes, Pôle de Biologie, Rennes, France;
5. Centre for Immunology and Infection, Department of Biology, Hull York Medical School, University of York, York, United Kingdom;
6. Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada; and
7. Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada